EP1357978A4 - Therapie genique aux cellules souches hematopoietiques - Google Patents

Therapie genique aux cellules souches hematopoietiques

Info

Publication number: EP1357978A4
Authority: EP; European Patent Office
Prior art keywords: stem cells; gene therapy; haematopoietic stem; haematopoietic; therapy
Prior art date: 2000-10-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP01986714A

Other languages

German (de)

English (en)

Other versions

EP1357978A2 (fr

Inventor

Richard Boyd

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Norwood Immunology Ltd

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-13

Filing date

2001-10-12

Publication date

2004-05-19

2000-10-13 Priority claimed from AUPR0745A external-priority patent/AUPR074500A0/en

2001-09-26 Priority claimed from US09/966,576 external-priority patent/US20020071833A1/en

2001-10-12 Application filed by Individual filed Critical Individual

2003-11-05 Publication of EP1357978A2 publication Critical patent/EP1357978A2/fr

2004-05-19 Publication of EP1357978A4 publication Critical patent/EP1357978A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/46—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Virology (AREA)
Developmental Biology & Embryology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
AIDS & HIV (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Transplantation (AREA)
Mycology (AREA)
Tropical Medicine & Parasitology (AREA)
General Engineering & Computer Science (AREA)

EP01986714A 2000-10-13 2001-10-12 Therapie genique aux cellules souches hematopoietiques Withdrawn EP1357978A4 (fr)

Applications Claiming Priority (13)

Application Number	Priority Date	Filing Date	Title
US79530200A	2000-10-13	2000-10-13
US79528600A	2000-10-13	2000-10-13
AUPR0745A AUPR074500A0 (en)	2000-10-13	2000-10-13	Treatment of t cell disorders
AUPR074500		2000-10-13
US795302		2000-10-13
US795286		2000-10-13
US75891001A	2001-01-10	2001-01-10
US758910		2001-01-10
US966576		2001-09-26
US09/966,576 US20020071833A1 (en)	1999-04-15	2001-09-26	Hematopoietic stem cell gene therapy
US96951001A	2001-10-01	2001-10-01
US969510		2001-10-01
PCT/IB2001/002739 WO2002031110A2 (fr)	2000-10-13	2001-10-12	Therapie genique aux cellules souches hematopoietiques

Publications (2)

Publication Number	Publication Date
EP1357978A2 EP1357978A2 (fr)	2003-11-05
EP1357978A4 true EP1357978A4 (fr)	2004-05-19

Family

ID=27542982

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01986714A Withdrawn EP1357978A4 (fr)	2000-10-13	2001-10-12	Therapie genique aux cellules souches hematopoietiques

Country Status (10)

Country	Link
EP (1)	EP1357978A4 (fr)
JP (1)	JP2004511495A (fr)
KR (1)	KR20030082542A (fr)
CN (1)	CN1582178A (fr)
AP (1)	AP2003002800A0 (fr)
AU (1)	AU1632002A (fr)
BR (1)	BR0114639A (fr)
CA (1)	CA2462073A1 (fr)
IL (1)	IL155413A0 (fr)
WO (1)	WO2002031110A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040258672A1 (en) *	1999-04-15	2004-12-23	Monash University	Graft acceptance through manipulation of thymic regeneration
JP2007518699A (ja) *	2003-04-18	2007-07-12	ノーウッド・イミュノロジー・リミテッド	胸腺再生前の病気の予防およびワクチン接種
HUE028958T2 (en)	2008-02-08	2017-01-30	Medimmune Llc	Anti-ifnar1 antibodies with reduced fc ligand affinity
RU2604490C2 (ru)	2010-11-05	2016-12-10	Займворкс Инк.	ДИЗАЙН УСТОЙЧИВОГО ГЕТЕРОДИМЕРНОГО АНТИТЕЛА С МУТАЦИЯМИ В Fc ДОМЕНЕ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996014853A1 (fr) *	1994-11-10	1996-05-23	University Of Washington	Implantation intrathymique de cellules souches
AUPP977899A0 (en) *	1999-04-15	1999-05-13	Monash University	Improvement of t cell mediated immunity

2001
- 2001-10-12 AP APAP/P/2003/002800A patent/AP2003002800A0/en unknown
- 2001-10-12 IL IL15541301A patent/IL155413A0/xx unknown
- 2001-10-12 BR BR0114639-4A patent/BR0114639A/pt not_active Application Discontinuation
- 2001-10-12 WO PCT/IB2001/002739 patent/WO2002031110A2/fr not_active Ceased
- 2001-10-12 AU AU1632002A patent/AU1632002A/xx active Pending
- 2001-10-12 JP JP2002534480A patent/JP2004511495A/ja active Pending
- 2001-10-12 KR KR10-2003-7005255A patent/KR20030082542A/ko not_active Ceased
- 2001-10-12 CA CA002462073A patent/CA2462073A1/fr not_active Abandoned
- 2001-10-12 CN CNA018201385A patent/CN1582178A/zh active Pending
- 2001-10-12 EP EP01986714A patent/EP1357978A4/fr not_active Withdrawn

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number	Publication date
AP2003002800A0 (en)	2003-06-30
CA2462073A1 (fr)	2002-04-18
CN1582178A (zh)	2005-02-16
BR0114639A (pt)	2004-01-20
WO2002031110A3 (fr)	2002-06-20
KR20030082542A (ko)	2003-10-22
IL155413A0 (en)	2003-11-23
WO2002031110A2 (fr)	2002-04-18
AU1632002A (en)	2002-04-22
JP2004511495A (ja)	2004-04-15
EP1357978A2 (fr)	2003-11-05

Publication	Publication Date	Title
DE60137510D1 (de)	2009-03-12	Zellwandabbauende enzymvarianten
DE60319848D1 (de)	2008-04-30	Medikament mit mesenchym-stammzellen
DE60235140D1 (de)	2010-03-11	Brennstoffzelle
DE60223986D1 (de)	2008-01-24	Brennstoffzelle
DE60137420D1 (de)	2009-03-05	Brennstoffzelle
DE60038853D1 (de)	2008-06-26	Brennstoffzelle
NO20010797D0 (no)	2001-02-16	Enzym-batteri
DE60143221D1 (de)	2010-11-18	Solarzelle
FI20001914A0 (fi)	2000-08-30	Elektrodirakenne
DE60142947D1 (de)	2010-10-14	Brennstoffzelle
DE60141669D1 (de)	2010-05-12	Sekundärzellen mit Polabdichtungsstruktur
DE60041116D1 (de)	2009-01-29	Brennstoffzellenseparator
DE60218747D1 (de)	2007-04-19	Brennstoffzellen
GB0113118D0 (en)	2001-07-18	Stem Cells
DE50102644D1 (de)	2004-07-22	Niedertemperatur-brennstoffzelle
DE60230016D1 (de)	2009-01-08	Brennstoffzelle
AU2003216822A8 (en)	2003-10-08	Stem cell culture
DE60133465D1 (de)	2008-05-15	Elektrochemische struktur
DE60220608D1 (de)	2007-07-26	Brennstoffzelle
ATE465520T1 (de)	2010-05-15	Photovoltaische zelle
AU2001290078A1 (en)	2002-04-02	Stem cell therapy
NO20033624L (no)	2003-10-10	Matrise genekspresjon i chondrogenese
DE50212610D1 (de)	2008-09-18	Brennstoffzellenblock
GB0103779D0 (en)	2001-04-04	Fuel cells
EP1357978A4 (fr)	2004-05-19	Therapie genique aux cellules souches hematopoietiques

Legal Events

Date	Code	Title	Description
2003-09-19	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-11-05	17P	Request for examination filed	Effective date: 20030513
2003-11-05	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2003-11-05	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2004-05-19	A4	Supplementary search report drawn up and despatched	Effective date: 20040402
2004-05-19	RIC1	Information provided on ipc code assigned before grant	Ipc: 7A 61P 37/04 B Ipc: 7A 61P 37/00 B Ipc: 7A 61P 31/18 B Ipc: 7A 61K 35/28 A
2004-10-15	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1061988 Country of ref document: HK
2008-06-04	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: NORWOOD IMMUNOLOGY, LTD.
2008-06-04	RIN1	Information on inventor provided before grant (corrected)	Inventor name: NORWOOD IMMUNOLOGY, LTD.
2008-11-19	17Q	First examination report despatched	Effective date: 20081017
2009-10-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2009-11-11	18D	Application deemed to be withdrawn	Effective date: 20090428
2011-05-27	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1061988 Country of ref document: HK